(Q44280535)

English

Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide

scientific article published in April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

author name string

Javier Bolaños-Meade

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Judith E Karp

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Chuanfa Guo

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Clarence B Sarkodee-Adoo

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Aaron P Rapoport

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Michael L Tidwell

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Laxmi N Buddharaju

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

T Timothy Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Leukemia Research

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

313-321

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival for patients with acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of acute myeloid leukemia in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900177-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0145-2126(02)00177-7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44280535&oldid=2109107100"